A 2026 study highlights a drug-delivery challenge: similar lipid particle measurements do not guarantee similar intestinal performance. Emulsion and dry-emulsion developers must also address precipitation, stability, and reproducibility.
Drug developers use lipid-based drug delivery (LDD) to tackle poorly water-soluble compounds, yet a formulation that performs well in initial...